Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 04, 2007 15:00 ET | Source: Avigen, Inc.

Avigen Presents At the 37th Annual Meeting of the Society for Neuroscience

ALAMEDA, Calif., Nov. 4, 2007 (PRIME NEWSWIRE) -- Avigen, Inc. (Nasdaq:AVGN), a biopharmaceutical company innovating therapies for the treatment of chronic neurological conditions, today announced the...
November 03, 2007 15:30 ET | Source: Avigen, Inc.

Avigen's AV411 Shows Promising Initial Results for Neuropathic Pain

SALT LAKE CITY, Nov. 3, 2007 (PRIME NEWSWIRE) -- Avigen, Inc. (Nasdaq:AVGN), a biopharmaceutical company innovating therapeutics for neurological care, today announced first-in-patient top line data...
October 30, 2007 08:00 ET | Source: Avigen, Inc.

Avigen to Present At Upcoming Healthcare Conferences

ALAMEDA, Calif., Oct. 30, 2007 (PRIME NEWSWIRE) -- Avigen, Inc. (Nasdaq:AVGN), a biopharmaceutical company innovating therapies for the treatment of chronic neurological conditions, announced today...
October 24, 2007 08:00 ET | Source: Avigen, Inc.

Avigen Reports Third Quarter 2007 Financial Results

ALAMEDA, Calif., Oct. 24, 2007 (PRIME NEWSWIRE) -- Avigen, Inc. (Nasdaq:AVGN), a biopharmaceutical company innovating therapies for the treatment of chronic neurological conditions, today reported...
October 03, 2007 08:00 ET | Source: Avigen, Inc.

Avigen to Present At 2007 BIO Investor Forum

ALAMEDA, Calif., Oct. 3, 2007 (PRIME NEWSWIRE) -- Avigen, Inc. (Nasdaq:AVGN) a biopharmaceutical company innovating therapeutics for chronic neurological care, announced today that Chief Business...
September 18, 2007 08:00 ET | Source: Avigen, Inc.

Avigen to Present At UBS Global Life Sciences Conference

ALAMEDA, Calif., Sept. 18, 2007 (PRIME NEWSWIRE) -- Avigen, Inc. (Nasdaq:AVGN) a biopharmaceutical company innovating therapeutics for chronic neurological care, announced today that President and CEO...
September 05, 2007 08:00 ET | Source: Avigen, Inc.

Avigen Initiates European Multi-Center AV650 Phase II Spasticity Trial in Patients with Multiple Sclerosis

ALAMEDA, Calif., Sept. 5, 2007 (PRIME NEWSWIRE) -- Avigen, Inc. (Nasdaq:AVGN) a biopharmaceutical company innovating therapeutics for the treatment of neurological conditions, today announced the...
August 13, 2007 08:00 ET | Source: Avigen, Inc.

Avigen Initiates U.S. Clinical Development for AV411

ALAMEDA, Calif., Aug. 13, 2007 (PRIME NEWSWIRE) -- Avigen, Inc. (Nasdaq:AVGN), a biopharmaceutical company developing innovative therapies for the treatment of chronic neurological conditions, today...
July 25, 2007 08:00 ET | Source: Avigen, Inc.

Avigen Reports Second Quarter 2007 Financial Results

ALAMEDA, Calif., July 25, 2007 (PRIME NEWSWIRE) -- Avigen, Inc. (Nasdaq:AVGN) a biopharmaceutical company developing innovative therapies for the treatment of chronic neurological conditions, today...
June 26, 2007 12:58 ET | Source: Avigen, Inc.

Expert Opinion Highlights Avigen's AV411 as Potential New Therapeutic for Neuropathic Pain and Opioid Withdrawal

ALAMEDA, Calif., June 26, 2007 (PRIME NEWSWIRE) -- Avigen, Inc. (Nasdaq:AVGN), a biopharmaceutical company innovating therapeutics for the treatment of neurological conditions, announced today that...